Combined Research on CJC-1295 & Ipamorelin When introduced together, CJC-1295 and Ipamorelin may influence GH regulation through distinct yet complementary pathways
Lawrence ECN, et al
Biologic therapies have transformed Crohn's disease management and include several FDA-approved options: TNF- inhibitors : Infliximab (Remicade), adalimumab (Humira), and certolizumab pegol (Cimzia) block tumor necrosis factor-alpha, a key pro-inflammatory cytokine
Two clicks will be heard after the second click, keep holding down the button until the yellow bar stops moving
They included 12 SGLT2i trials with 73,238 participants, of whom 3,065 were on a GLP-1 RA: they found that the benefits of SGLT2i on MACE were consistent regardless of background GLP-1 RA use (HR = 0.81 in patients receiving GLP-1 RA vs HR = 0.90 in those not receiving GLP-1RA) with no significant heterogeneity (p = 0.31)
Moreover, their potential as monotherapy for sequential control of MASLD warrants further investigation